35195223|t|Serum levels of irisin and nesfatin-1 in multiple sclerosis.
35195223|a|BACKGROUND: Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune chronic neurological disease. Currently, there are no effective serum biomarkers to verify MS diagnosis, to assess disease prognosis, and evaluate response to MS treatment. OBJECTIVE: The present study is a preliminary assessment of irisin and nesfatin-1 serum levels in patients with relapsing- remitting MS (RRMS). METHODS: A total of 86 participants, 42 patients with RRMS diagnosis and 44 healthy controls were included in the study. The serum irisin and nesfatin-1 parameters of the patients and control group members were analyzed. RESULTS: Irisin and nesfatin-1 levels of the RRMS patients were significantly lower than the controls (z: -3.82, p<0.001; z: -4.79, p<0.001, respectively) The cut-off level of irisin is 10.390 (ng/mL) (sensitivity: 84.1%, specificity: 71.4%, AUC: 0.800), and the cut-off level of nestatin-1 is 7.155 (ng/mL) (sensitivity: 68.2%, specificity: 64.3%, AUC: 0.739) in the ROC analysis. For these cut-off levels in the case-control groups, the lower irisin and nesfatin-1 levels are the independent variables for MS patients (OR 9.723, 95%CI 2.884-32.785, p<0.001; OR 3.992, 95%CI 1.336-11.928, p<0.001) respectively. CONCLUSION: The present study revealed lower irisin and nesfatin-1 levels in patients with RRMS. These findings suggest that the decreased levels of irisin and nesfatin-1 peptides may contribute to MS pathogenesis such as inflammation, oxidative stress, and apoptosis in MS, leading to demyelination, axonal damage with neuronal loss, and gliosis.
35195223	16	22	irisin	Gene	252995
35195223	27	37	nesfatin-1	Gene	4925
35195223	41	59	multiple sclerosis	Disease	MESH:D009103
35195223	73	91	Multiple sclerosis	Disease	MESH:D009103
35195223	93	95	MS	Disease	MESH:D009103
35195223	103	115	inflammatory	Disease	MESH:D007249
35195223	138	148	autoimmune	Disease	MESH:D001327
35195223	149	177	chronic neurological disease	Disease	MESH:D002908
35195223	240	242	MS	Disease	MESH:D009103
35195223	308	310	MS	Disease	MESH:D009103
35195223	382	388	irisin	Gene	252995
35195223	393	403	nesfatin-1	Gene	4925
35195223	420	428	patients	Species	9606
35195223	434	457	relapsing- remitting MS	Disease	MESH:D020529
35195223	459	463	RRMS	Disease	MESH:D020529
35195223	506	514	patients	Species	9606
35195223	520	524	RRMS	Disease	MESH:D020529
35195223	597	603	irisin	Gene	252995
35195223	608	618	nesfatin-1	Gene	4925
35195223	637	645	patients	Species	9606
35195223	696	702	Irisin	Gene	252995
35195223	707	717	nesfatin-1	Gene	4925
35195223	732	736	RRMS	Disease	MESH:D020529
35195223	737	745	patients	Species	9606
35195223	863	869	irisin	Gene	252995
35195223	1132	1138	irisin	Gene	252995
35195223	1143	1153	nesfatin-1	Gene	4925
35195223	1195	1197	MS	Disease	MESH:D009103
35195223	1198	1206	patients	Species	9606
35195223	1345	1351	irisin	Gene	252995
35195223	1356	1366	nesfatin-1	Gene	4925
35195223	1377	1385	patients	Species	9606
35195223	1391	1395	RRMS	Disease	MESH:D020529
35195223	1449	1455	irisin	Gene	252995
35195223	1460	1470	nesfatin-1	Gene	4925
35195223	1498	1500	MS	Disease	MESH:D009103
35195223	1522	1534	inflammation	Disease	MESH:D007249
35195223	1571	1573	MS	Disease	MESH:D009103
35195223	1586	1599	demyelination	Disease	MESH:D003711
35195223	1601	1614	axonal damage	Disease	MESH:D001480
35195223	1620	1633	neuronal loss	Disease	MESH:D009410
35195223	1639	1646	gliosis	Disease	MESH:D005911
35195223	Association	MESH:D009410	4925
35195223	Negative_Correlation	MESH:D020529	252995
35195223	Association	MESH:D009103	252995
35195223	Association	MESH:D001480	4925
35195223	Negative_Correlation	MESH:D020529	4925
35195223	Association	MESH:D003711	4925
35195223	Association	MESH:D009103	4925

